期刊文献+

骨肉瘤miR-96的表达与细胞增殖和凋亡 被引量:2

miR-96 expression in osteosarcoma and the role in cell proliferation and apoptosis
下载PDF
导出
摘要 背景与目的:微小RNA(microRNA,miRNA)是一类内源性的非编码小分子RNA,其主要通过与靶mRNA作用抑制转录后的翻译。miR-96是在多类肿瘤细胞中高表达的小RNA分子。本研究旨在检测miR-96在骨肉瘤组织中的表达,并研究其在骨肉瘤细胞的增殖、细胞周期及凋亡中的意义。方法:运用TagMan MGB探针法检测40例骨肉瘤组织及对应的骨组织中miR-96的表达;应用反义技术降低骨肉瘤细胞(U2-OS和MG-63)中miR-96的表达;采用MTT比色法检测细胞增殖的改变;应用流式细胞技术检测骨肉瘤细胞细胞周期和凋亡情况。结果:在40例骨肉瘤组织中,62.5%(25/40)的骨肉瘤组织miR-96表达明显高于对应骨组织(P<0.05);反义miR-96转染骨肉瘤细胞U2-OS和MG-63后,miR-96的表达明显降低,U2-OS和MG-63骨肉瘤细胞生长受到明显抑制,其生长主要停滞在G0/G1期,而S期和G2/M期细胞的比例下降。另外,降低miR-96的表达,U2-OS和MG-63骨肉瘤细胞早期凋亡明显增加。结论:miR-96在骨肉瘤组织中表达明显上调,降低其表达能明显抑制U2-OS和MG-63骨肉瘤细胞的生长,并诱导细胞早期凋亡增加,miR-96可能成为骨肉瘤基因表达调控的新靶点。 Background and purpose: MicroRNAs are small non-coding endogenous RNA molecules that can inhibit protein translation partly through binding with target mRNAs. MiR-96 is over expressed in many kinds of human tumor cells. The present study aimed to investigate the expression of miR-96 in osteosarcoma tissues and demonstrate its role in osteosarcoma cell lines proliferation, cell cycle and apoptosis. Methods: The expressions of miR-96 in 40 pairs of osteosarcoma and their adjacent nontumorous tissues were detected by TagMan MGB probe method. The antisense technology was used to decrease the expression of miR-96 in osteosarcoma ceils (U2-OS, MG- 63), MTT assay and flow cytometry were performed to investigate the effect of miR-96 on the cell proliferation, cell cycles and apoptosis. Results: We examined miR-96 expression levels in 40 pairs of human osteosarcoma and their corresponding nontumorous tissues, miR-96 was found to be over-expressed in 62.5% (25/40) of the osteosarcoma cases (P〈0.05). The cell growth ability of U2-OS and MG-63 cells was significantly inhibited following transfection of antisense-microRNA-oligonucleotides-96 (AMO-miR-96). U2-OS and MG-63 cells were mainly detained in Go/ G1, and the percentage of cells at S and G2/M decreased. In addition, knocking down the expression of miR-96 in U2-OS and MG-63 cells resulted in an increase in early apoptosis. Conclusion: miR-96 is over-expressed in human osteosarcoma. Inhibition ofmiR-96 expression can not only effectively suppress the growth of U2-OS and MG-63 cells, but also induce cell apoptosis. MiR-96 may serve as a new molecular target for the regulation of gene expression in osteosarcoma.
出处 《中国癌症杂志》 CAS CSCD 北大核心 2013年第4期285-291,共7页 China Oncology
关键词 骨肉瘤 miR-96 反义单核苷酸 肿瘤抑制 Osteosarcoma miR-96 Antisense oligonucleotides
  • 相关文献

参考文献14

  • 1CAMPBELL W C, CANALE S T, BEATY J H. Campbell' s Operative Orthopaedics [ M ] . 11^th edition, Mosby, 2008: 901-902.
  • 2ZENG Y. Principles of micro-RNA production and maturation [ J ] . Oncogene, 2006, 25(46): 6156-6162.
  • 3CROCE C M. Causes and consequences of microRNA dysregulation in cance[ J ] . Nat Rev Genet, 2009, 10(10): 704-714.
  • 4WANG Y, LUO H, LI Y, et al. hsa-miR-96 up-regulates MAP4K1 and IRS1 and may function as a promising diagnostic marker in human bladder urothelial carcinomas [ J ] . Mol Med Report, 2012, 5(1): 260-265.
  • 5LIN H, DAI T, XIONG H, et al. Unregulated miR-96 induces cell proliferation in human breast cancer by down regulating transcriptional factor FOXO3a [ J ] . PLoS One, 2010, 5(12): e15797.
  • 6ZHU W, LIU X, HE J, et al. Overexpression of members of the mieroRNA-183 family is a risk factor for lung cancer: a case control study [ J ] . BMC Cancer, 2011, 11: 393.
  • 7SARVER A L, FRENCH A J, BORRALHO P M, et al. Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states [ J ] . BMC Cancer, 2009, 9: 401.
  • 8STEFANI G, SLACK F J. Small non-coding RNAs in animal development [ J ]. Nat Rev Mol Cell Biol 2008, 9(3): 219- 230.
  • 9ESQUELA-KERSCHER A, SLACK F J. Oncomirs microRNAs with a role in cancer [ J ] . Nat Rev Cancer, 2006, 6(4): 259-269.
  • 10CALIN G A, CROCE C M. MicroRNA signatures in human cancers [ J ] . Nat Rev Cancer, 2006, 6(11): 857-866.

同被引文献31

  • 1OITAVIANI Q, JAFLFE N. The epidemiology of osteosarcoma [J]. Cancer Treat Res, 2009, 152: 3-13.
  • 2ECKSTEIN F. Small non-coding RNAs as magic bullets [J]. Trends Biochem Sci, 2005, 30(8): 445-452.
  • 3WU W, SUN M, ZOU G M, et al. MicroRNA and cancer: Current status and prospective [J]. Int J Cancer, 2007, 120(5): 953-960.
  • 4PETRI A, LINDOW M, KAUPPINEN S. MicroRNA silencing in primates: towards development of novel therapeutics [J]. Cancer Res, 2009, 69(2): 393-395.
  • 5MAIRE G, MARTIN J W, YOSHIMOTO M, et al. Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma [J]. Cancer Genet, 2011, 204(3): 138-146.
  • 6HU H, ZHANG Y, CAl X H, et al. Changes in microRNA expression in the MG-63 osteosarcoma cell line compared with osteoblasts [J]. Oncol Lett, 2012, 4(5): 1037-1042.
  • 7NAKAJIMA M, HAYASHI K, EGI Y. Effect of Wf-536, an ovel ROCK inhibitor, against metastasis of B16 melanoma [J] . Cancer Chemother Pharmacol, 2003, 52(4): 319-324.
  • 8ZHENG R, IW ASE A, SHEN R. Neuropeptide-stimulated cell migration in prostate cancer cells is mediated by RhoA kinase signaling and inhibited by neutral endopeptidase [J]. Oncogene, 2006, 25(44): 5942-595.
  • 9AMBROS V. microRNAs: tiny regulators with great potential [J]. Cell, 2001, 107(7): 823-826.
  • 10BARTEL D P. MicroRNAs: genomics, biogenesis, mechanism, and function [J]. Cell, 2004, 116(2): 281-297.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部